Patient-Relevant Costs for Organ Preservation versus Radical Resection in Locally Advanced Rectal Cancer

ORCID
0000-0002-8751-9862
Zugehörigkeit
Department of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany;
Wurschi, Georg W.;
ORCID
0000-0003-2022-897X
Zugehörigkeit
Department of Radiation Oncology, University of Freiburg—Medical Center, 79106 Freiburg, Germany
Rühle, Alexander;
Zugehörigkeit
Department of Radiation Oncology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany(A.F.)
Domschikowski, Justus;
ORCID
0000-0003-2864-4273
Zugehörigkeit
Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, Germany
Trommer, Maike;
ORCID
0000-0002-0361-728X
Zugehörigkeit
Department of Radiation Oncology, Cyberknife and Radiotherapy, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, Germany
Ferdinandus, Simone;
ORCID
0000-0001-6972-0899
Zugehörigkeit
Department of Radiotherapy, Hannover Medical School, 30625 Hannover, Germany
Becker, Jan-Niklas;
Zugehörigkeit
Department of Radiation Oncology, University Hospital Tübingen, 72076 Tübingen, Germany
Boeke, Simon;
ORCID
0000-0002-8123-4962
Zugehörigkeit
Department of Radiotherapy, Hannover Medical School, 30625 Hannover, Germany
Sonnhoff, Mathias;
ORCID
0000-0001-8222-2288
Zugehörigkeit
Department of Radiation Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany
Fink, Christoph A.;
Zugehörigkeit
Department of Radiation Oncology, University Hospital, LMU Munich, 81377 Munich, Germany
Käsmann, Lukas;
Zugehörigkeit
Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, 01307 Dresden, Germany
Schneider, Melanie;
Zugehörigkeit
Department of Radiotherapy and Radiation Oncology, University Hospital Hamburg-Eppendorf, 20251 Hamburg, Germany
Bockelmann, Elodie;
ORCID
0000-0001-8811-5416
Zugehörigkeit
Department of Radiation Oncology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany(A.F.)
Krug, David;
Zugehörigkeit
Department of Radiation Oncology, University of Leipzig Medical Center, 04103 Leipzig, Germany
Nicolay, Nils H.;
Zugehörigkeit
Department of Radiation Oncology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany(A.F.)
Fabian, Alexander;
Zugehörigkeit
Department of Radiotherapy and Radiation Oncology, Jena University Hospital, 07747 Jena, Germany;
Pietschmann, Klaus

Simple Summary Patients with locally advanced rectal cancer and complete remission after “total neoadjuvant therapy” may undergo a “watch and wait” schedule instead of radical resection, but need to be followed-up more frequently. This is the first work analyzing patient-related costs in this setup in the German health care system compared to standard chemoradiotherapy and resection. In this model, patients undergoing watch and wait had a better quality of life, but experienced additional costs from more frequent follow-up visits. Overall, these were cumulatively less than individual costs for medication and ostomy care after radical resection. Thus, organ preservation appeared to be efficacious and cost-effective from a patient’s point of view in the German health care system. Abstract Total neoadjuvant therapy (TNT) is an evolving treatment schedule for locally advanced rectal cancer (LARC), allowing for organ preservation in a relevant number of patients in the case of complete response. Patients who undergo this so-called “watch and wait” approach are likely to benefit regarding their quality of life (QoL), especially if definitive ostomy could be avoided. In this work, we performed the first cost-effectiveness analysis from the patient perspective to compare costs for TNT with radical resection after neoadjuvant chemoradiation (CRT) in the German health care system. Individual costs for patients insured with a statutory health insurance were calculated with a Markov microsimulation. A subgroup analysis from the prospective “FinTox” trial was used to calibrate the model’s parameters. We found that TNT was less expensive (−1540 EUR) and simultaneously resulted in a better QoL (+0.64 QALYs) during treatment and 5-year follow-up. The average cost for patients under TNT was 4711 EUR per year, which was equivalent to 3.2% of the net household income. CRT followed by resection resulted in higher overall costs for ostomy care, medication and greater loss of earnings. Overall, TNT appeared to be more efficacious and cost-effective from a patient’s point of view in the German health care system.

Zitieren

Zitierform:
Zitierform konnte nicht geladen werden.

Rechte

Rechteinhaber: © 2024 by the authors.

Nutzung und Vervielfältigung: